SEMNUR PHARMACEUTICALS

semnur-pharmaceuticals-logo

Semnur Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of innovative products that meet the needs of pain management practitioners and their patients.

#SimilarOrganizations #People #Financial #Website #More

SEMNUR PHARMACEUTICALS

Industry:
Biotechnology Life Science Pharmaceutical

Founded:
2013-01-01

Address:
Los Altos, California, United States

Country:
United States

Website Url:
http://www.semnurpharma.com

Total Employee:
1+

Status:
Active

Contact:
888-315-8706

Email Addresses:
cmccarrick@semnurpharma.com

Total Funding:
6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

jaisim-shah_image

Jaisim Shah Board Of Directors @ Semnur Pharmaceuticals
Board_member
2013-01-01

brent-ahrens_image

Brent Ahrens Board Member @ Semnur Pharmaceuticals
Board_member

james-topper_image

James Topper Board of Directors @ Semnur Pharmaceuticals
Board_member

Current Employees Featured

mahendra-g-shah_image

Mahendra G. Shah
Mahendra G. Shah Executive Chairman @ Semnur Pharmaceuticals
Executive Chairman

jaisim-shah_image

Jaisim Shah
Jaisim Shah President & Chief Executive Officer @ Semnur Pharmaceuticals
President & Chief Executive Officer
2013-01-01

Investors List

vivo-capital_image

Vivo Capital

Vivo Capital investment in Venture Round - Semnur Pharmaceuticals

canaan-partners_image

Canaan Partners

Canaan Partners investment in Venture Round - Semnur Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Venture Round - Semnur Pharmaceuticals

Official Site Inspections

http://www.semnurpharma.com

  • Host name: 74-208-236-40.elastic-ssl.ui-r.com
  • IP address: 74.208.236.40
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Semnur Pharmaceuticals"

Semnurpharma – Getting back to normal

Back pain affects most adults, causes disability for some, and is a common reason for seeking healthcare. In the United States, opioid prescription for low back pain has increased, and opioids are now the most commonly prescribed …See details»

Overview – Semnurpharma

Novel Non-opioid Pain Management Medications Under Development. Semnur Pharmaceuticals, Inc. is a biopharmaceutical company focused on the clinical and commercial development of …See details»

Semnur Pharmaceuticals, Inc. | LinkedIn

Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial development of innovative products and therapeutics that meet the needs of pain …See details»

Our Team – Semnurpharma

Semnurpharma - Getting back to normal Getting back to normal. About. Overview; Leadership Team; Board of Directors; Our Culture; Partners; Chronic Back Pain. Chronic Back Pain; SP …See details»

Semnur Pharmaceuticals - Crunchbase Company Profile & Funding

Contact Email cmccarrick@semnurpharma.com Phone Number 888-315-8706 Semnur Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the …See details»

Semnur Pharmaceuticals Company Profile | Management and

Www.semnurpharma.com Semnur Pharmaceuticals Profile and History Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial …See details»

Semnur Pharmaceuticals - PitchBook

Semnur Pharmaceuticals General Information Description. Developer of non-opioid drugs designed for the treatment of lumbar radicular pain. The company's drugs focus on the clinical …See details»

Semnur Pharmaceuticals - VentureRadar

Semnur develops innovative products for pain management practitioners and their patients. ... Find out more about Semnur Pharmaceuticals, Healthcare, Life Sciences and Specialty …See details»

Partners – Semnurpharma

Semnurpharma - Getting back to normal Getting back to normal. About. Overview; Leadership Team; Board of Directors; Our Culture; Partners; Chronic Back Pain. Chronic Back Pain; SP …See details»

Semnur Pharmaceuticals - Craft

See insights on Semnur Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Semnur Pharmaceuticals, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Semnur Pharmaceuticals, Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»

Overview, News & Similar companies - ZoomInfo.com

Jan 7, 2018 Who is Semnur Pharmaceuticals. Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial development of innovative …See details»

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex ...

Nov 6, 2024 As previously announced, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: …See details»

Investor Overview – Semnurpharma

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces on November 6th, 2024 the Filing of a Registration Statement on Form S-4 by …See details»

Semnur Pharmaceuticals to go public in SPAC deal of up to $2 …

Jul 2, 2024 Drug developer Semnur Pharmaceuticals said on Tuesday it has signed a letter of intent to go public through a merger with special purpose acquisition company Denali Capital …See details»

Leadership Team – Semnurpharma

Henry Ji brings 25+ years of experience in the biotechnology and life sciences industry. Dr. Ji has been Chairman of Scilex from March 2019 to present and served as the CEO of Scilex …See details»

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex ...

Sep 3, 2024 Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. (Nasdaq: …See details»

Semnur Pharmaceuticals Begins Pivotal Phase 3 Trial For SP-102 In ...

Jan 7, 2018 For more information, visit www.semnurpharma.com or www.clearbackpainstudy.com. Follow us on LinkedIn , Facebook , Twitter , and Clear Back …See details»

Our Culture – Semnurpharma

Our Culture. At Semnur Pharmaceuticals, we are not just your average pharmaceutical company. We are a passionate team of talented individuals united by a shared mission to make a …See details»

NEWS – Semnurpharma

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces on November 6th, 2024 the Filing of a Registration Statement on Form S-4 by …See details»

linkstock.net © 2022. All rights reserved